Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study https://www.diffusionpharma.com/wp-content/uploads/2020/08/AdobeStock_276012266-scaled.jpeg 2560 1707 Diffusion Pharmaceuticals Inc. https://www.diffusionpharma.com/wp-content/uploads/2020/08/AdobeStock_276012266-scaled.jpegCHARLOTTESVILLE, Va., March 25, 2021 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.